Dabigatran and Parnaparin: Interaction Details
- Dabigatran
- Pradaxa
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Dabigatran and Parnaparin interaction:
Parnaparin
We don't have a drug information page for Parnaparin yet. Have a question about Parnaparin? Ask a pharmacist, free →
What Happens When You Take Dabigatran With Parnaparin
What can happen when they are taken together (rated Major)
An increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Bleeding risk is elevated with dabigatran etexilate, and the resulting can be substantial and in some cases fatal. This risk rises further when dabigatran etexilate is given together with other agents that also heighten bleeding risk, among them.
Any signs or symptoms suggesting blood loss (eg, or a decrease in hemoglobin and/or hematocrit) should be assessed without delay, and dabigatran etexilate should be stopped in patients who have active pathological bleeding. In patients undergoing spinal puncture or receiving neuraxial anesthesia, may additionally raise the risk of spinal or epidural hematomas, which can lead to long-term or permanent paralysis.21
The Dabigatran and Parnaparin Interaction, Explained
Dabigatran (Pradaxa) and parnaparin are both . Each one helps stop harmful clots from forming, but they work in different ways. When they are taken together, their effects can add up, which can raise your chance of bleeding. This concern comes mostly from how the drugs work, not from large studies, but it is still taken seriously.
Watch for signs like unusual bruising, nosebleeds or bleeding gums that won't stop, pink or dark urine, black or bloody stools, or feeling dizzy or weak. Keep taking your medicines as prescribed, and tell your pharmacist or doctor right away if you notice any of these. Your care team can plan and monitor this safely.
Mechanism: , anticoagulation. Dabigatran (a direct thrombin ; the etexilate is activated by esterases, and this does not alter the interaction) combined with parnaparin (an LMWH, antithrombin-mediated anti-Xa > anti-IIa activity). No PK interaction is expected.
- Effect: Increased bleeding risk, which may be significant or fatal. Severity is major. Onset is unspecified. Evidence is theoretical.
- Neuraxial risk: Increased risk of epidural or spinal hematoma, with possible permanent paralysis, with neuraxial anesthesia or spinal puncture.
- Management: is generally limited to deliberate transitions between agents. Promptly evaluate signs of blood loss (drop in Hgb/Hct, ). Discontinue dabigatran if active pathological bleeding occurs.
See the 2 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Dabigatran and Parnaparin Interact
The likely mechanism
effects
How to Manage the Dabigatran and Parnaparin Interaction
Because both medicines thin the blood, your care team will usually plan carefully how and when they are used together. For example, they often time things closely when switching from one to the other. They may also monitor you more closely for bleeding, which can include checking your blood counts.
- Keep taking both exactly as prescribed. Do not stop either one on your own.
- Report bleeding, black stools, blood in your urine, dizziness, or weakness right away.
- Tell your care team before any spinal or epidural procedure or spinal tap.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Dabigatran or Parnaparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: PRADAXA oral capsules, dabigatran etexilate oral capsules
A study found that giving subcutaneous enoxaparin 40 mg daily for 3 days before a single oral dose of dabigatran did not affect dabigatran exposure, and it did not alter the coagulation parameters of aPTT, ecarin clotting time, or thrombin time.1
Dabigatran and Parnaparin: Common Questions
How serious is the Dabigatran and Parnaparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Dabigatran and Parnaparin interaction managed?
Because both medicines thin the blood, your care team will usually plan carefully how and when they are used together. For example, they often time things closely when switching from one to the other. They may also monitor you more closely for bleeding, which can include checking your blood counts. Keep taking both exactly as prescribed. Do not stop either one on your own. Report bleeding, black s… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Dabigatran and Parnaparin Interaction
Ask in your own words about taking Dabigatran and Parnaparin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (2)
- Product Information: PRADAXA(R) oral capsules, dabigatran etexilate oral capsules. Boehringer Ingelheim Pharmaceuticals Inc (per FDA), Ridgefield, CT, 2023. DailyMed
- Product Information: PRADAXA(R) oral pellets, dabigatran etexilate oral pellets. Boehringer Ingelheim Pharmaceuticals Inc (per FDA), Ridgefield, CT, 2023. DailyMed
Other Serious Interactions of Dabigatran and Parnaparin
Also serious with Dabigatran
Also serious with Parnaparin
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Dabigatran
- St. John's WortMajor
- Activated CharcoalMajor
- PiracetamMajor
- Vitamin EModerate
- SeleniumModerate
- GingerModerate
- TurmericModerate
- Green TeaModerate
- + 233 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.